Why Novo Nordisk’s CEO has learned to trust his gut feeling
Listen now
Description
Lars Fruergaard Jørgensen, CEO of the company which makes game-changing obesity drugs Ozempic and Wegovy, explains how its culture and long-view underpin its recent turnaround.
More Episodes
Published 09/26/24
Read our magazine, I by IMD, here. Discover IMD's leadership programmes here.
Published 08/20/24